Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 3, Randomized, Double-blind, Placebo/Active-controlled, Parallel-arm Trial to Assess Efficacy, Safety, and Pharmacokinetics of Dasiglucagon Relative to Placebo/GlucaGen as Rescue Therapy for Severe Hypoglycemia in Children With T1DM Treated With Insulin

Trial Profile

Phase 3, Randomized, Double-blind, Placebo/Active-controlled, Parallel-arm Trial to Assess Efficacy, Safety, and Pharmacokinetics of Dasiglucagon Relative to Placebo/GlucaGen as Rescue Therapy for Severe Hypoglycemia in Children With T1DM Treated With Insulin

Recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Feb 2019

At a glance

  • Drugs Dasiglucagon
  • Indications Hypoglycaemia
  • Focus Registrational; Therapeutic Use
  • Sponsors Zealand Pharma
  • Most Recent Events

    • 04 Feb 2019 New source identified and integrated European Clinical Trials Database EudraCT2018-000892-33
    • 15 Nov 2018 According to a Zealand Pharma media release, data readout from the trial is expected in 1H 2019.
    • 27 Sep 2018 Status changed from not yet recruiting to recruiting, according to a Zealand Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top